William Blair Starts TransMedics Group (TMDX) at Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts TMDX Hot Sheet
Price: $72.76 +8.05%
Rating Summary:
12 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 11 | New: 1
Rating Summary:
12 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 11 | New: 1
Join SI Premium – FREE
William Blair analyst Ryan Daniels initiates coverage on TransMedics Group (NASDAQ: TMDX) with a Outperform rating.
For an analyst ratings summary and ratings history on TransMedics Group click here. For more ratings news on TransMedics Group click here.
Shares of TransMedics Group closed at $96.07 yesterday.
You May Also Be Interested In
- Chardan Starts Vicore Pharma Holding (VCRE) at Buy
- UBS Downgrades StoneCo Ltd. (STNE) to Neutral
- Citi Starts TCL Electronics Holdings (1070:HK) at Buy
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
